Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Promaxo
AddedFeb 15, 2024
UpdatedJun 18, 2026
Promaxo

Promaxo

Promaxo: Innovating patient care with customer-centric MRI systems and technologies.

HQ
Oakland, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Promaxo, founded with a mission to revolutionize patient care, focuses on developing and commercializing customer-centric MRI systems and related technologies. Their innovative products are designed to enhance patient outcomes and redefine the standard of care in medical diagnostics. Promaxo's MRI systems are tailored for use in physician offices, enabling real-time diagnosis and treatment, thereby making advanced imaging more accessible and convenient for both doctors and patients.

Promaxo has garnered attention from notable medical professionals and investors, reflecting its potential to significantly impact the healthcare industry. Key achievements include the successful development and deployment of their MRI systems in various clinical settings. The company's technology has been praised for its ability to bring MRI capabilities directly to the point of care, thus broadening access to critical diagnostic tools and improving patient management.

Promaxo - Similar Companies

PMX logo

PMX

Promedix logo

Promedix

promedixinc.com

Neuro42 logo

Neuro42

Smart Choice MRI logo

Smart Choice MRI

smartchoicemri.com

Alpha-Mri logo

Alpha-Mri

HeartVista logo

HeartVista

Petcoil logo

Petcoil

petcoil.com

Imaginostics logo

Imaginostics

imaginostics.com

Proxamama logo

Proxamama

proxamama.com

Medmo logo

Medmo

medmo.com

Exo logo

Exo

exo.inc

Iradimed logo

Iradimed

iradimed.com

MedicaMetrix logo

MedicaMetrix

medicametrix.com

Eyas Medical Imaging logo

Eyas Medical Imaging

eyasmri.com

Moximed logo

Moximed

moximed.com

Promaxo - Quick Facts

Who are Promaxo's competitors?

Companies similar to Promaxo include PMX, Promedix, Neuro42 and Smart Choice MRI.

When was Promaxo founded?

Promaxo was founded in 2016.

Where is Promaxo's headquarters located?

Promaxo's headquarters is located in Oakland, CA, US.

How much has Promaxo raised to-date?

As of Oct 10, 2023, Promaxo has raised a total of $28.8M (USD).

How many employees does Promaxo have?

Promaxo has 89 employees as of Feb 5, 2024.

Promaxo - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Technology
  • MRI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Imaging
  • MRI Systems
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified